tradmap

NGVT Ingevity Corp

$73.73 -0.89%

Data as of close

Basic Materials · Chemicals & Allied Products

Ingevity Corp (NGVT) is a basic materials company in the Chemicals & Allied Products industry, with a market capitalization of $2.5 billion. Shares last traded at $73.73, 8.4% below their 52-week high. Over the past year the stock is up 37.9%. NGVT trades at a price-to-earnings ratio of 46.94, above the Chemicals & Allied Products median of 38.51. Net profit margin is 4.7%, above the peer median of -4.2%. Revenue declined 2.7% year over year.

Market Cap
$2.5B
Shares Out
34.4M
EPS (TTM)
$1.51
P/E (TTM)*
46.94
P/S Ratio
2.18
P/B Ratio
54.04
Dividend / Share
—
Dividend Yield
—
52-Week High
$80.50
52-Week Low
$45.87
Volume (venue)
35,612
Avg Vol (3m, venue)
14,030.889

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+3.71%
1M
+1.74%
3M
-2.51%
6M
-0.12%
YTD
+24.61%
1Y
+37.86%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
58.56
SMA (50)
$70.51
SMA (200)
$71.30
Price vs SMA50
+4.57%
Price vs SMA200
+3.41%
ATR (14)
$2.06

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$1.2B
Net Income
$54M
Gross Margin
41.1%
Operating Margin
36.1%
Net Margin
4.7%
Return on Equity
115.1%
Return on Assets
3.5%
Current Ratio
1.61
Debt / Equity
27.86
Revenue Growth (YoY)
-2.7%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $1.00 2026-07-30
Q1 2026 $1.66 2026-05-07
Q4 2025 (derived) -$2.33 2026-02-26
FY 2025 -$4.61 2026-02-26
Q3 2025 $1.18 2025-11-06
Q2 2025 -$4.02 2025-08-05

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Chemicals & Allied Products peers

NGVT vs 14 industry peers (Chemicals & Allied Products), by market cap. Data as of close

P/E vs peers
46.94 / 38.51 med
+22% premium
P/S vs peers
2.18 / 1.83 med
+19% premium
Net margin vs peers
4.7% / -4.2% med
above median
1–14 of 14
SOLSSolstice Advanced Materials Inc.$9.4B44.562.295.1%-2.68%
BCPCBalchem Corp$5.5B32.465.0015.4%+2.63%
PRMPerimeter Solutions, Inc.$4.6B—6.08-44.9%+0.16%
NGVTIngevity Corp$2.5B46.942.184.7%-0.89%
IOSPInnospec Inc.$2.5B21.041.336.3%-0.40%
OLNOlin Corp$2.1B—0.31-3.3%+3.30%
CCChemours Co$2.0B—0.34-5.2%-2.66%
HUNHuntsman Corp$1.7B—0.31-5.0%+3.32%
ECVTEcovyst Inc.$1.1B—1.27-7.1%-0.49%
FMCFmc Corp$1.0B———+5.09%
SLIStandard Lithium Ltd.$333M———-2.80%
ADURADURO CLEAN TECHNOLOGIES INC.$284M———-5.79%
ACNTASCENT INDUSTRIES CO.$124M—1.48-5.3%-1.36%
CITRCitroTech Inc.$56M—41.43—+3.77%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.